The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I

BACKGROUND: FDG-PET/CT is part of the standard diagnostic management of a patients with a large variety of common and less common malignant tumors, based on the increased glucose metabolism within tumors. CASE PRESENTATION: A hybrid fluorodeoxyglucose positron emission tomography and computed tomogr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schöffski, Patrick, Deroose, Christophe M, Gheysens, Olivier, Lips, Nele, Slabbaert, Koen, Vancleynenbreugel, Ben, Moerman, Philippe, Peetermans, Willy E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071334/
https://www.ncbi.nlm.nih.gov/pubmed/24885974
http://dx.doi.org/10.1186/1471-2342-14-19
Descripción
Sumario:BACKGROUND: FDG-PET/CT is part of the standard diagnostic management of a patients with a large variety of common and less common malignant tumors, based on the increased glucose metabolism within tumors. CASE PRESENTATION: A hybrid fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) was performed in a neurofibromatosis patient to rule out relapse of malignant peripheral nerve sheet tumor. The scan revealed non-malignant neurofibromas, a testis seminoma and hypermetabolic syphilitic granulomata. CONCLUSION: This case stresses the need to rule out infectious diseases when atypical hypermetabolic lesions are present.

Ejemplares similares